Evaluation of minimal residual disease using next generation flow cytometry in patients with AL amyloidosis

被引：0
|
作者：
Kastritis, Efstathios [1 ]
Fotiou, Despina [2 ]
Kostopoulos, Ioannis [1 ]
Theodorakakou, Foteini [1 ]
Terpos, Evangelos [1 ]
Gavriatopoulou, Maria [3 ]
Spiliopoulou, Vasiliki [3 ]
Ntanasis-Stathopoulos, Ioannis [3 ]
Malandrakis, Panagiotis [1 ]
Kanellias, Nikolaos [3 ]
Roussou, Maria [1 ]
Magdalini, Migkou [4 ]
Eleutherakis-Papaiakovou, Evangelos [3 ]
Solia, Eirini [2 ]
Papathoma, Alexandra [4 ]
Tsitsilonis, Ourania [3 ]
Dimopoulos, Meletios Athanasios
机构：
[1] Ethniko Kai Kapodistriako Panepistemio Athenon, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Athens, Greece
[4] Natl & Kapodistrian Univ Athens, Alexandra Hosp, Dept Oncol, Dept Clin Therpaeut,Sch Med, Athens, Greece
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
156
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [41] Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow Cytometry
    Ho, Caleb
    Syed, Mustafa
    Roshal, Mikhail
    Petrova-Drus, Kseniya
    Moung, Christine
    Yao, Jinjuan
    Quesada, Andres E.
    Benhamida, Jamal
    Vanderbilt, Chad
    Liu, Ying
    Zhu, Menglei
    Yu, Wayne
    Maciag, Lidia
    Wang, Meiyi
    Ma, Yuanyuan
    Gao, Qi
    Rustad, Even H.
    Hultcrantz, Malin
    Diamond, Benjamin T.
    Zheng-Lin, Binbin
    Huang, Ying
    Hutt, Kasey
    Miller, Jeffrey E.
    Dogan, Ahmet
    Nafa, Khedoudja
    Landgren, Ola
    Arcila, Maria E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2021, 23 (02): : 181 - 199
  • [42] Clinical value of minimal residual disease assessed by multiparameter flow cytometry in amyloid light chain amyloidosis
    Xiaozhe Li
    Beihui Huang
    Junru Liu
    Meilan Chen
    Jingli Gu
    Juan Li
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 913 - 919
  • [43] Clinical value of minimal residual disease assessed by multiparameter flow cytometry in amyloid light chain amyloidosis
    Li, Xiaozhe
    Huang, Beihui
    Liu, Junru
    Chen, Meilan
    Gu, Jingli
    Li, Juan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (04) : 913 - 919
  • [44] Minimal residual disease negativity by next-generation flow in non-CR myeloma patients
    Kim, Sung-Min
    Yang, Naery Euphrasia
    Jeong, Dajeong
    Yun, Jiwon
    Ryu, Sohee
    Yoon, Sung-Soo
    Ahn, Yong-Oon
    Lee, Dong Soon
    EJHAEM, 2020, 1 (02): : 563 - 566
  • [45] Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy
    Terpos, Evangelos
    Kostopoulos, Ioannis, V
    Kastritis, Efstathios
    Ntanasis-Stathopoulos, Ioannis
    Migkou, Magdalini
    Rousakis, Pantelis
    Argyriou, Alexandra T.
    Kanellias, Nikolaos
    Fotiou, Despina
    Eleutherakis-Papaiakovou, Evangelos
    Gavriatopoulou, Maria
    Ziogas, Dimitrios C.
    Papanota, Aristea-Maria
    Spyropoulou-Vlachou, Marilyn
    Trougakos, Ioannis P.
    Tsitsilonis, Ourania E.
    Paiva, Bruno
    Dimopoulos, Meletios A.
    HEMASPHERE, 2019, 3 (06):
  • [46] MINIMAL RESIDUAL DISEASE MONITORING IN MULTIPLE MYELOMA USING POLYCHROMATIC FLOW CYTOMETRY
    Rihova, Lucie
    Varmuzova, Tamara
    Zarbochova, Pavla
    Suska, Renata
    Penka, Miroslav
    Hajek, Roman
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (06) : 404 - 405
  • [47] What does minimal residual disease mean in AL amyloidosis?
    Milani, Paolo
    Merlini, Giampaolo
    Palladini, Giovanni
    EXPERT OPINION ON ORPHAN DRUGS, 2018, 6 (12): : 703 - 705
  • [48] Monitoring minimal residual disease in the bone marrow using next generation sequencing
    Rustad, Even H.
    Boyle, Eileen M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (01)
  • [49] Prognostic Significance of Circulating Plasma Cells Detected By Next Generation Flow Cytometry in Light (AL) Chain Amyloidosis
    Kastritis, Efstathios
    Kostopoulos, Ioannis, V
    Theodorakakou, Foteini
    Roussakis, Pantelis
    Panteli, Chrysanthi
    Orologas-Stavrou, Nikolaos
    Spiliopoulou, Vasiliki
    Migkou, Magdalini
    Papanikolaou, Asimina
    Gakiopoulou, Harikleia
    Fotiou, Despina
    Terpos, Evangelos
    Tsitsilonis, Ourania E.
    Dimopoulos, Meletios A.
    BLOOD, 2022, 140 : 1150 - 1151
  • [50] Minimal residual disease in multiple myeloma: Benefits of flow cytometry
    Galtseva, I. V.
    Davydova, Y. O.
    Kapranov, N. M.
    Julhakyan, H. L.
    Mendeleeva, L. P.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (01) : 12 - 20
12345